MediWound - 11 Year Stock Price History | MDWD

Historical daily share price chart and data for MediWound since 2014 adjusted for splits and dividends. The latest closing stock price for MediWound as of June 27, 2025 is 19.26.
  • The all-time high MediWound stock closing price was 127.12 on March 21, 2014.
  • The MediWound 52-week high stock price is 24.00, which is 24.6% above the current share price.
  • The MediWound 52-week low stock price is 14.14, which is 26.6% below the current share price.
  • The average MediWound stock price for the last 52 weeks is 18.05.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
MediWound Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 18.3673 18.0000 22.2400 14.9700 19.2600 8.20%
2024 16.4622 11.2500 21.1600 11.2500 17.8000 75.02%
2023 10.3800 13.2900 14.1700 7.1800 10.1700 -24.61%
2022 13.0271 18.2000 22.6800 8.4700 13.4900 -18.34%
2021 28.5606 26.3900 42.3500 15.4000 16.5200 -36.22%
2020 21.1048 21.6300 29.0150 10.2550 25.9000 19.35%
2019 26.7752 29.8200 38.5000 18.0600 21.7000 -23.65%
2018 39.6403 31.8500 51.4500 27.3000 28.4200 -8.76%
2017 41.3298 36.7500 54.6000 29.7500 31.1500 -2.82%
2016 50.5528 59.2900 63.7000 32.0544 32.0544 -46.38%
2015 52.2460 48.1460 72.5200 35.0700 59.7800 28.23%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.208B $0.020B
MediWound Ltd. is a biotechnology niche specialty company. It is focused on developing, manufacturing and commercializing products that address unmet needs in the fields of severe burn and chronic wound management. The company is also developing NexoBrid for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns. MediWound Ltd. is headquartered in Yavne, Israel.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $86.719B 32.53
Zoetis (ZTS) United States $69.528B 25.94
Takeda Pharmaceutical (TAK) Japan $48.047B 9.56
Daiichi Sankyo, - (DSNKY) Japan $43.343B 22.21
BeOne Medicines - (ONC) Cayman Islands $26.436B 0.00
Sandoz Group AG (SDZNY) Switzerland $23.802B 0.00
Merck (MKKGY) Germany $17.015B 12.47
Summit Therapeutics (SMMT) United States $15.299B 0.00
Shionogi (SGIOY) Japan $14.887B 14.91
United Therapeutics (UTHR) United States $12.823B 11.34
Neurocrine Biosciences (NBIX) United States $12.412B 42.52
Orion OYJ (ORINY) Finland $10.495B 28.38
IPSEN (IPSEY) France $9.739B 0.00
Corcept Therapeutics (CORT) United States $7.765B 63.12
Stevanato Group S.p.A (STVN) Italy $7.462B 45.63
Madrigal Pharmaceuticals (MDGL) United States $6.678B 0.00
Ionis Pharmaceuticals (IONS) United States $6.335B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Grifols, S.A (GRFS) Spain $6.092B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.382B 13.33
Soleno Therapeutics (SLNO) United States $4.195B 0.00
Hypermarcas (HYPMY) Brazil $3.072B 20.21
Crinetics Pharmaceuticals (CRNX) United States $2.805B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.657B 9.31
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.548B 13.78
NewAmsterdam Pharma (NAMS) Netherlands $2.085B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.959B 0.00
ARS Pharmaceuticals (SPRY) United States $1.787B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.754B 0.00
Endo (NDOI) United States $1.603B 0.00
Evotec AG (EVO) Germany $1.477B 0.00
Ocular Therapeutix (OCUL) United States $1.469B 0.00
Guardian Pharmacy Services (GRDN) United States $1.353B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.167B 23.35
Harrow (HROW) United States $1.133B 0.00
Dyne Therapeutics (DYN) United States $1.088B 0.00
Enliven Therapeutics (ELVN) United States $1.015B 0.00
Verve Therapeutics (VERV) United States $1.007B 0.00
Collegium Pharmaceutical (COLL) United States $0.962B 5.19
Akebia Therapeutics (AKBA) United States $0.959B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.890B 0.00
Ardelyx (ARDX) United States $0.883B 0.00
Elite Pharmaceuticals (ELTP) United States $0.760B 0.00
Xeris Biopharma Holdings (XERS) United States $0.735B 0.00
Cronos Group (CRON) Canada $0.733B 0.00
USANA Health Sciences (USNA) United States $0.580B 12.60
Xencor (XNCR) United States $0.579B 0.00
KalVista Pharmaceuticals (KALV) United States $0.567B 0.00
Relay Therapeutics (RLAY) United States $0.566B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.564B 0.00
Theravance Biopharma (TBPH) United States $0.561B 0.00
Bioventus (BVS) United States $0.556B 14.10
Zevra Therapeutics (ZVRA) United States $0.492B 0.00
AleAnna (ANNA) United States $0.481B 0.00
Organogenesis (ORGO) United States $0.466B 0.00
Siga Technologies (SIGA) United States $0.462B 9.64
Tourmaline Bio (TRML) United States $0.425B 0.00
Oruka Therapeutics (ORKA) United States $0.415B 0.00
Savara (SVRA) United States $0.382B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.348B 9.41
Heron Therapeutics (HRTX) United States $0.326B 0.00
Aquestive Therapeutics (AQST) United States $0.323B 0.00
Nektar Therapeutics (NKTR) United States $0.320B 0.00
Altimmune (ALT) United States $0.284B 0.00
Nature's Sunshine Products (NATR) United States $0.268B 24.58
Tonix Pharmaceuticals Holding (TNXP) United States $0.257B 0.00
Liminatus Pharma (LIMN) United States $0.247B 0.00
Aldeyra Therapeutics (ALDX) United States $0.227B 0.00
Nanobiotix S.A (NBTX) France $0.213B 0.00
OmniAb (OABI) United States $0.208B 0.00
Esperion Therapeutics (ESPR) United States $0.197B 0.00
ProKidney (PROK) United States $0.196B 0.00
Larimar Therapeutics (LRMR) United States $0.194B 0.00
Profound Medical (PROF) Canada $0.180B 0.00
4D Molecular Therapeutics (FDMT) United States $0.178B 0.00
Journey Medical (DERM) United States $0.166B 0.00
Innate Pharma SA (IPHYF) France $0.163B 0.00
Aclaris Therapeutics (ACRS) United States $0.159B 0.00
Galectin Therapeutics (GALT) United States $0.147B 0.00
Avita Medical (RCEL) United States $0.144B 0.00
Lexeo Therapeutics (LXEO) United States $0.137B 0.00
Lyell Immunopharma (LYEL) United States $0.132B 0.00
Inhibikase Therapeutics (IKT) United States $0.120B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.118B 0.00
Cardiol Therapeutics (CRDL) Canada $0.117B 0.00
Korro Bio (KRRO) United States $0.113B 0.00
VAXART, INC (VXRT) United States $0.113B 0.00
Protara Therapeutics (TARA) United States $0.111B 0.00
Champions Oncology (CSBR) United States $0.107B 17.64
Corbus Pharmaceuticals Holdings (CRBP) United States $0.091B 0.00
Arch Biopartners (ACHFF) Canada $0.090B 0.00
Nutriband (NTRB) United States $0.089B 0.00
Unicycive Therapeutics (UNCY) United States $0.086B 0.00
Cassava Sciences (SAVA) United States $0.085B 0.00
Dominari Holdings (DOMH) United States $0.081B 0.00
Fractyl Health (GUTS) United States $0.080B 0.00
Vivani Medical (VANI) United States $0.078B 0.00
Achieve Life Sciences (ACHV) Canada $0.077B 0.00
Surrozen (SRZN) United States $0.077B 0.00
ESSA Pharma (EPIX) Canada $0.077B 0.00
Wellgistics Health (WGRX) United States $0.073B 0.00
Pyxis Oncology (PYXS) United States $0.068B 0.00
Assertio Holdings (ASRT) United States $0.062B 0.00
Context Therapeutics (CNTX) United States $0.059B 0.00
NRx Pharmaceuticals (NRXP) United States $0.059B 0.00
Gain Therapeutics (GANX) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Inotiv (NOTV) United States $0.058B 0.00
Rafael Holdings (RFL) United States $0.058B 0.00
PMV Pharmaceuticals (PMVP) United States $0.056B 0.00
Metagenomi (MGX) United States $0.055B 0.00
Avalo Therapeutics (AVTX) United States $0.052B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.048B 0.00
Telomir Pharmaceuticals (TELO) United States $0.046B 0.00
Century Therapeutics (IPSC) United States $0.045B 0.00
Prelude Therapeutics (PRLD) United States $0.044B 0.00
Mural Oncology (MURA) Ireland $0.043B 0.00
ElectroCore (ECOR) United States $0.040B 0.00
Iterum Therapeutics (ITRM) Ireland $0.040B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.039B 28.89
Karyopharm Therapeutics (KPTI) United States $0.038B 0.00
Acrivon Therapeutics (ACRV) United States $0.038B 0.00
PolyPid (PYPD) Israel $0.036B 0.00
Jupiter Neurosciences (JUNS) United States $0.035B 0.00
Enlivex Therapeutics (ENLV) Israel $0.028B 0.00
China SXT Pharmaceuticals (SXTC) China $0.027B 0.00
SCYNEXIS (SCYX) United States $0.027B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
Klotho Neurosciences (KLTO) United States $0.023B 0.00
VYNE Therapeutics (VYNE) United States $0.022B 0.00
FibroGen (FGEN) United States $0.021B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
DURECT (DRRX) United States $0.019B 0.00
Vivos Therapeutics (VVOS) United States $0.019B 0.00
BioLineRx (BLRX) Israel $0.019B 0.00
BioVie (BIVI) United States $0.019B 0.00
Lipocine (LPCN) United States $0.018B 0.00
Mannatech (MTEX) United States $0.017B 0.00
Carisma Therapeutics (CARM) United States $0.017B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.017B 0.00
Citius Pharmaceuticals (CTXR) United States $0.016B 0.00
Plus Therapeutics (PSTV) United States $0.016B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.016B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
CASI Pharmaceuticals (CASI) China $0.015B 0.00
Ernexa Therapeutics (ERNA) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.012B 2.17
Cosmos Health (COSM) United States $0.012B 0.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.010B 0.00
Ainos (AIMD) United States $0.010B 0.00
Crescent Biopharma (CBIO) United States $0.010B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.010B 0.00
Talphera (TLPH) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Alaunos Therapeutics (TCRT) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
SHINECO (SISI) China $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 8.16
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00